2 ) of 60 patients under treatment with short-acting high mg potency neuroleptics ( perphenazine greater than 16 mg daily and haloperidol greater than 2 mg daily ) nine patients ( 15 % ) required medication with anticholinergics , whereas 3 ) of 40 patients under treatment with long-acting ( depot ) neuroleptics , 17 ( 43 % ) had a need for anticholinergic medication ;
C0018546
haloperidol
C0040615
neuroleptics